Home Newsfeeds Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

Barclays Maintains Equal-Weight on Canadian Imperial Bank, Lowers Price Target to C$66

By Benzinga Newsdesk

December 2, 8:52 AM

Barclays analyst John Aiken maintains Canadian Imperial Bank (TSX:CM) with a Equal-Weight and lowers the price target from C$69 to C$66.

Analyst Upgrades Duolingo, Sees Very Different User Experience Than ChatGPT

By Nabaparna Bhattacharya

May 28, 2:20 PM

JMP Securities analyst upgrades Duolingo to Market Outperform, citing rollout of Max, improved subscription tiers, and conversational experience as growth catalysts, envisioning a distinct user experience from ChatGPT.

DUOL

BMO Capital Maintains Outperform on Walmart, Raises Price Target to $165

By Benzinga Newsdesk

November 16, 8:03 AM

BMO Capital analyst Kelly Bania maintains Walmart (NYSE:WMT) with a Outperform and raises the price target from $160 to $165.

WMT

Dave & Buster’s Gears Up For Q3 Print; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts

By Lisa Levin

December 5, 7:08 AM

Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) is projected to release financial results for its third quarter ended Oct. 29, 2023, after the closing bell on Dec. 5, 2023.

PLAY

Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Related Posts

Barclays Maintains Equal-Weight on Canadian Imperial Bank, Lowers Price Target to C$66

Analyst Upgrades Duolingo, Sees Very Different User Experience Than ChatGPT

BMO Capital Maintains Outperform on Walmart, Raises Price Target to $165

Dave & Buster’s Gears Up For Q3 Print; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts